So, in the past the CEO said he was going to put FebriDx aside and focus on the services business to generate revenue. However, here we are again with another FDA application for FebriDx.
This should see the share price plummet once more during 2023. Oh, and again, no real update on what's happening with ViraDx. It was supposed to be in the US market months ago. Another false promise by Lumos Diagnostics. Are we surprised? No.
It looks like there will be no news until early 2024. See you then.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
So, in the past the CEO said he was going to put FebriDx aside...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add LDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.003(6.98%) |
Mkt cap ! $22.51M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 3.9¢ | $151.3K | 3.681M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 56263 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 235000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 56263 | 0.040 |
5 | 1414708 | 0.039 |
4 | 1163242 | 0.038 |
2 | 235136 | 0.037 |
3 | 450000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 235000 | 4 |
0.042 | 200000 | 1 |
0.043 | 319225 | 2 |
0.044 | 225952 | 4 |
0.045 | 2988 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |